Compare Edwards Lifesciences Corporation Common Stock (EW) vs Lumen Technologies Inc (LUMN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Lumen Technologies Inc — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $85.1 (market cap $48.56B), while Lumen Technologies Inc trades at $5.42 (market cap $5.73B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 8.5× Lumen Technologies Inc's market cap, and Edwards Lifesciences Corporation Common Stock is trading nearer its 52-week high, Lumen Technologies Inc nearer its low. Which is the better fit depends on your goals.
| EW | LUMN | |
|---|---|---|
Market Cap | $48.56B | $5.73B |
Volume | 6,520,488 | 17,079,799 |
Sector | Health | Media |
52-Week High | $95.18 | $11.83 |
52-Week Low | $72.65 | $5.53 |
Enterprise Value | $45.01B | $17.35B |
Typical Hold Time | — | 40 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
LUMN trades at $5.91, up 0.08% on the day, with a bearish technical signal. The company reported a net loss of $1.74 billion in 2025, though revenue remains substantial at $12.40 billion. Recent news highlights a Nasdaq listing move and new AI-focused networking services, aiming to capitalize on enterprise demand. Cash flow trends show operational strength but negative net cash flow in 2025. The stock's valuation metrics include a low P/S of 0.47 but negative profitability ratios.
The outlook is mixed, with deep value from low P/S and strategic AI initiatives offering growth potential, but high debt, consistent losses, and bearish analyst consensus pose significant risks. Investors face a speculative turnaround play dependent on successful execution of new strategies amid steep legacy declines.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Lumen Technologies Inc
With 450,000 route miles of fiber, including over 35,000 route miles of subsea fiber connecting Europe, Asia, and Latin America, Lumen Technologies is one of the United States' largest telecommunications carriers serving global enterprises. Its merger with Level 3 further shifted the company's operations toward businesses (over 70% of revenue) and away from its legacy consumer business. Lumen offers businesses a full menu of communications services, providing colocation and data center services, data transportation, and end-user phone and internet service. On the consumer side, Lumen provides broadband and phone service across 37 states, where it has 4.5 million broadband customers.
Read more on LUMN →
